Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for attention-deficit/hyperactivity disorder

Biological Psychiatry

Volumn 57, Issue 11, 2005, Pages 1410-1415

  Volkow, Nora D ^a,b,c   Wang, Gene Jack ^c   Fowler, Joanna S ^c   Ding, Yu Shin ^c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dopamine; Dopamine transporter; Methylphenidate; Saliency

Indexed keywords

CARBON 11; DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; PLACEBO; RACLOPRIDE; RADIOLIGAND;

ATTENTION DEFICIT DISORDER; BRAIN DYSFUNCTION; BRAIN RADIOGRAPHY; CLINICAL TRIAL; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; ENANTIOMER; HUMAN; ISOTOPE LABELING; MENTAL PERFORMANCE; NEUROTRANSMISSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; SYNAPSE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; CLINICAL TRIALS; DIAGNOSTIC IMAGING; DOPAMINE; HUMANS; METHYLPHENIDATE; TIME FACTORS;

EID: 20444366879     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.11.006     Document Type: Review

References (56)

1. C.J. Aman, R.J. Roberts Jr, B.F. Pennington A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder Frontal lobe versus right parietal lobe theories Dev Psychol 34 1998 956 969
2. K.C. Berridge, T.E. Robinson What is the role of dopamine in reward Hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28 1998 309 369
3. G. Bush, J.A. Frazier, S.L. Rauch, L.J. Seidman, P.J. Whalen, M.A. Jenike Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop Biol Psychiatry 45 1999 1542 1552
4. R.N. Cardinal, D.R. Pennicott, C.L. Sugathapala, T.W. Robbins, B.J. Everitt Impulsive choice induced in rats by lesions of the nucleus accumbens core Science 292 2001 2499 2501
5. F.X. Castellanos Toward a pathophysiology of attention-deficit/ hyperactivity disorder Clin Pediatr (Phila) 36 1997 381 393
6. F.X. Castellanos, J. Elia, M.J. Kruesi, W.L. Marsh, C.S. Gulotta, W.Z. Potter Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder Neuropsychopharmacology 14 1996 125 137
7. C.K. Conners The effect of dexedrine on rapid discrimination and motor control of hyperkinetic children under mild stress J Nerv Ment Dis 142 1966 429 433
8. E.H. Cook Jr, M.A. Stein, M.D. Krasowski, N.J. Cox, D.M. Olkon, J.E. Kieffer Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 56 1995 993 998
9. Y.S. Ding, J.S. Fowler, N.D. Volkow, S.L. Dewey, G.J. Wang, J. Logan Chiral drugs Comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain Psychopharmacology (Berl) 131 1997 71 78
10. W.M. Dinn, N.C. Robbins, C.L. Harris Adult attention-deficit/ hyperactivity disorder Neuropsychological correlates and clinical presentation Brain Cogn 46 2001 114 121
11. D.D. Dougherty, A.A. Bonab, T.J. Spencer, S.L. Rauch, B.K. Madras, A.J. Fischman Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 1999 2132 2133
12. R.P. Ebstein, L. Nemanov, I. Klotz, I. Gritsenko, R.H. Belmaker Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking Mol Psychiatry 2 1997 472 477
13. D. Efron, F. Jarman, M. Barker Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder A double-blind, crossover trial Pediatrics 100 1997 662 666
14. M. Ernst, A.J. Zametkin, J.A. Matochik, P.H. Jons, R.M. Cohen DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study J Neurosci 18 1998 5901 5907
15. M. Ernst, A.J. Zametkin, J.A. Matochik, D. Pascualvaca, P.H. Jons, R.M. Cohen High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder Am J Psychiatry 156 1999 1209 1215
16. S.V. Faraone, J. Sergeant, C. Gilberg, J. Biederman The worldwide prevalence of ADHD Is it an American condition? World J Biol Psychiatry 2 2003 104 113
17. F.J. Files, M.N. Branch, D. Clody Effects of methylphenidate on responding under extinction in the presence and absence of conditioned reinforcement Behav Pharmacol 1 1989 113 121
18. J.N. Giedd, J. Blumenthal, E. Molloy, F.X. Castellanos Brain imaging of attention deficit/hyperactivity disorder Ann NY Acad Sci 931 2001 33 49
19. M. Gill, G. Daly, S. Heron, Z. Hawi, M. Fitzgerald Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Mol Psychiatry 2 1997 311 313
20. B.E. Golinko Side effects of dextroamphetamine and methylphenidate in hyperactive children-a brief review Prog Neuropsychopharmacol Biol Psychiatry 8 1984 1 8
21. L.L. Greenhill, J.M. Halperin, H. Abikoff Stimulant medications J Am Acad Child Adolesc Psychiatry 38 1999 503 512
22. L.L. Greenhill, S. Pliszka, M.K. Dulcan, W. Bernet, V. Arnold, J. Beitchman Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Child Adolesc Psychiatry 41 suppl 2 2002 26S 49S
23. E. Heiligenstein, L.M. Conyers, A.R. Berns, M.A. Miller, M.A. Smith Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students J Am Coll Health 46 1998 185 188
24. J.R. Hollerman, W. Schultz Dopamine neurons report an error in the temporal prediction of reward during learning Nat Neurosci 1 1998 304 309
25. N. Ilgin, S. Senol, K. Gucuyener, N. Gokcora, S. Sener Is increased D2 receptor availability associated with response to stimulant medication in ADHD Dev Med Child Neurol 43 2001 755 760
26. E.A. Kiyatkin, G.V. Rebec Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats J Neurophysiol 75 1996 142 153
27. J. Konopacki, K. Gralewicz, S. Gralewicz, M.K. Lewinska Amphetamine anorexia in cats The effect of encouraging to ingestive behavior Acta Physiol Pol 36 1985 267 269
28. G.F. Koob Hedonic valence, dopamine and motivation Mol Psychiatry 1 1996 186 189
29. K.H. Krause, S.H. Dresel, J. Krause, H.F. Kung, K. Tatsch Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder Effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett 285 2000 107 110
30. R. Kuczenski, D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine Comparison with amphetamine J Neurochem 68 1997 2032 2037
31. G.J. LaHoste, J.M. Swanson, S.B. Wigal, C. Glabe, T. Wigal, N. King Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder Mol Psychiatry 1 1996 121 124
32. D.A. Marsteller, M.R. Gerasimov, W.K. Schiffer, J.M. Geiger, C.R. Barnett, J.S. Borg Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex Neuropsychopharmacology 27 2002 163 170
33. S. Overmeyer, E. Taylor Neuroimaging in hyperkinetic children and adults An overview Pediatr Rehabil 4 2000 57 70
34. K.S. Patrick, R.W. Caldwell, R.M. Ferris, G.R. Breese Pharmacology of the enantiomers of threo-methylphenidate J Pharacol Exp Ther 241 1987 152 158
35. L.J. Porrino, J.L. Rapoport, D. Behar, D.R. Ismond, W.E. Bunney Jr A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects Arch Gen Psychiatry 40 1983 688 693
36. M.L. Pucak, A.A. Grace Regulation of substantia nigra dopamine neurons Crit Rev Neurobiol 9 1994 67 89
37. N.R. Richardson, A. Gratton Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement An electrochemical study in rat J Neurosci 16 1996 8160 8169
38. D.C. Rowe, C. Stever, L.N. Giedinghagen, J.M. Gard, H.H. Cleveland, S.T. Terris Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder Mol Psychiatry 3 1998 419 426
39. P. Seeman, B.K. Madras Anti-hyperactivity medication Methylphenidate and amphetamine Mol Psychiatry 3 1998 386 396
40. A. Shenker The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder Focus on catecholamine receptor pharmacology Adv Pediatr 39 1992 337 382
41. M.V. Solanto Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder A review and integration Behav Brain Res 94 1998 127 152
42. J. Swanson, S. Wigal, L. Greenhill, R. Browne, B. Waslick, M. Lerner Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting Psychopharmacol Bull 34 1998 55 60
43. J.M. Swanson, D. Cantwell, M. Lerner, K. McBurnett, G. Hanna Effects of stimulant medication on learning in children with ADHD J Learn Disabil 24 1991 219 230 255
44. J.M. Swanson, S. Gupta, L. Williams, D. Agler, M. Lerner, S. Wigal Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD Effects on activity level in the classroom and on the playground J Am Acad Child Adolesc Psychiatry 41 2002 1306 1314
45. J.M. Swanson, J.A. Sergeant, E. Taylor, E.J. Sonuga-Barke, P.S. Jensen, D.P. Cantwell Attention-deficit hyperactivity disorder and hyperkinetic disorder Lancet 351 1998 429 433
46. J.M. Swanson, G.A. Sunohara, J.L. Kennedy, R. Regino, E. Fineberg, T. Wigal Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD) A family-based approach Mol Psychiatry 3 1998 38 41
47. M.H. Teicher, C.M. Anderson, A. Polcari, C.A. Glod, L.C. Maas, P.F. Renshaw Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry Nat Med 6 2000 470 473
48. C.H. van Dyck, D.M. Quinlan, L.M. Cretella, J.K. Staley, R.T. Malison, R.M. Baldwin Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder Am J Psychiatry 159 2002 309 312
49. N.D. Volkow, Y.S. Ding, J.S. Fowler, G.J. Wang, J. Logan, J.S. Gatley Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain Arch Gen Psychiatry 52 1995 456 463
50. N.D. Volkow, G. Wang, J.S. Fowler, J. Logan, M. Gerasimov, L. Maynard Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain J Neurosci 21 2001 RC121
51. N.D. Volkow, G.J. Wang, J.S. Fowler, S.J. Gatley, J. Logan, Y.S. Ding Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 1998 1325 1331
52. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, M. Jayne, D. Franceschi "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect Synapse 44 2002 175 180
53. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, D. Schlyer, R. Hitzemann Imaging endogenous dopamine competition with [11C]raclopride in the human brain Synapse 16 1994 255 262
54. N.D. Volkow, G.J. Wang, J.S. Fowler, F. Telang, L. Maynard, J. Logan Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain Am J Psychiatry 161 2004 1173 1180
55. I.D. Waldman, D.C. Rowe, A. Abramowitz, S.T. Kozel, J.H. Mohr, S.L. Sherman Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children Heterogeneity owing to diagnostic subtype and severity Am J Hum Genet 63 1998 1767 1776
56. C.L. Wyvell, K.C. Berridge Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward Enhancement of reward "wanting" without enhanced "liking" or response reinforcement J Neurosci 20 2000 8122 8130